BA
The Boeing Company
BA offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
EXPO
Exponent, Inc.
EXPO has the edge over BA overall, supported by stronger valuation and lower modeled downside.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
EXPO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Strong | |
| Strong |
EXPO's revenue, profitability, cash flow and balance sheet are all currently healthy.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA has the edge over EXPO in the historical PE scenario, which offers more potential upside but is not a forecast.
EXPO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 33x | $86.22 | — |
| Cheap | 36x | $82.56 | -4.2% |
| Current | 37x | $86.22 | — |
| Fair | 47x | $109 | +27% |
| Expensive | 55x | $127 | +48% |
Historical ranges are pointers, not guarantees.
EXPO's PE is in its cheap range at 37x. If earnings grow as analysts expect, today's price would be 33x next year's earnings.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect BA to return to profit, with revenue growing. However, they disagree widely on these estimates.
EXPO Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for EXPO, with profitability improving.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has returned to profit: it earned $9.66 per share over the past year, after losing money the year before.
EXPO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.58 | +12% |
| Q3 2026 | $2.31 | +13% |
| Q2 2026 | $2.22 | +12% |
| Q1 2026 | $2.14 | +4.9% |
| Q4 2025 | $2.07 | -1.9% |
| Q3 2025 | $2.04 | -1% |
| Q2 2025 | $1.99 | -2.5% |
| Q1 2025 | $2.04 | +3.6% |
| Q4 2024 | $2.11 | +8.8% |
EXPO has the edge over BA on earnings, with more consistent year-over-year improvement.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA's revenue has grown year over year for seven quarters in a row: $24.2B last quarter, up 3.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
EXPO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $173.7M | +18% |
| Q2 2026 | $171.6M | +21% |
| Q1 2026 | $166.3M | +14% |
| Q4 2025 | $147.4M | +7.8% |
| Q3 2025 | $147.1M | +8% |
| Q2 2025 | $142M | +1% |
| Q1 2025 | $145.5M | +0.4% |
| Q4 2024 | $136.8M | +11% |
EXPO's revenue has grown year over year for 11 quarters in a row: $174M last quarter, up 18% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 24% | +4.4 points |
| Q2 2026 | 16% | +4.2 points |
| Q1 2026 | 25% | -5.7 points |
| Q4 2025 | 20% | -0.2 points |
| Q3 2025 | 20% | +0.8 points |
| Q2 2025 | 12% | -13 points |
| Q1 2025 | 31% | +9.3 points |
| Q4 2024 | 20% | +5 points |
EXPO has the edge over BA on profitability, with a higher operating margin.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over EXPO on cash flow, with more consistent year-over-year improvement.
EXPO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $62.1M | +107% |
| Q2 2026 | $29.1M | -14% |
| Q1 2026 | -$3.4M | -162% |
| Q4 2025 | $52.9M | -1% |
| Q3 2025 | $30M | +7.1% |
| Q2 2025 | $33.9M | -28% |
| Q1 2025 | $5.5M | -38% |
| Q4 2024 | $53.5M | -23% |
EXPO generated $141M in free cash flow over the past year, up 14% from the year before.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has 793M diluted shares, up 4.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
EXPO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.2% | -565K shares |
| 1 year | -5.4% | -2.8M shares |
| 3 years | -6.2% | -3.2M shares |
| 5 years | -9.2% | -4.9M shares |
| Available history | -10% | -5.4M shares |
EXPO has the edge over BA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $67.4M |
| Q1 2026 | $78.8M |
| Q4 2025 | $24.4M |
| Q3 2025 | $40M |
| Q4 2024 | $1,000 |
| Q3 2024 | $1,000 |
| Q2 2024 | $244,000 |
EXPO spent $171M buying back its own shares over the past year.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
EXPO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.8x | Net Cash |
| Q2 2026 | -0.5x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -1.7x | Net Cash |
| Q3 2025 | -1.6x | Net Cash |
| Q2 2025 | -1.9x | Net Cash |
| Q1 2025 | -1.7x | Net Cash |
| Q4 2024 | -2.0x | Net Cash |
EXPO has the edge over BA on leverage, with a lower net debt burden relative to earnings.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
EXPO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 73.5 | Overbought |
| Stochastic | 82.5 | Overbought |
EXPO's weekly RSI is 73 (overbought) and its Stochastic is 83 (overbought).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA has the edge over EXPO on valuation relative to its sector.
EXPO PE vs Industrials Sector
| Metric | EXPO | Sector median | Relative |
|---|---|---|---|
| PE | 37x | 24x | 55% above |
| PE % | 21 | 58 | 37 pts below |
EXPO is trading at 37x earnings, a 55% premium to the Industrials sector's median of 24x.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
EXPO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $75.1 | 15% above |
| 20 week MA | $69.7 | 24% above |
| 50 week MA | $68.2 | 27% above |
| 100 week MA | $72.7 | 19% above |
| 200 week MA | $83.0 | 3.9% above |
EXPO has the edge over BA on trend strength, trading above more of its moving averages.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.
EXPO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $69.5 | $88.8 | +28% |
| 2021 | $88.8 | $114.0 | +28% |
| 2022 | $114.0 | $100.6 | -12% |
| 2023 | $100.6 | $88.0 | -12% |
| 2024 | $88.0 | $89.4 | +1.6% |
| 2025 | $89.4 | $71.4 | -20% |
| 2026 YTD | $71.4 | $86.2 | +21% |
EXPO has the edge over BA on returns for 2026, with the stronger performance.